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• Although there have been reports on the use of 
medicines, food supplements and foods for 
performance enhancement, little is known about the 
prevalence, off-label uses pattern and associated 
risks in Portugal.  
• Continued use of these lifestyle drugs can lead to 
physical and psychological dependence, and 
present severe interactions with other drugs and 
alcohol, thus representing an opportunity for 
pharmaceutical counselling and guidance. 
INTRODUCTION 
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• Therapeutic consumption for enhanced performance 
was reported by 71.9% of those inquired. Medicines 
(36.9%), food supplements (33.7%) and foods 
(29.4%) were equally consumed. Risk perception (in 
a scale 1-5) was higher for drugs (ranging between 
2.9 and 4.09) and lower for natural products (2.37-
3.44), but undervalued by users since consumption 
is sporadic.  
• Amongst medicine consumers, psychotropic drugs 
were by far the most used (76.5%), represented 
mainly by anxiolytics (53.6% for the herbal medicine 
or food supplement valerian and 16.8% for 
alprazolam) and the anti-depressant fluoxetine 
(3.5%). Reported off-label uses take advantage of 
the indirect effects resulting from anxiety/depression 
control (e.g. better response to daily professional 
requirements). 
• Foods and food supplements were classified 
according to their alleged function. Energizing drinks 
represent 39.9% of the total consumption of these 
products, followed by memory or concentration 
enhancers (25.3%). 52% of the food supplements 
consumed were sold in pharmacies strengthening 
the idea that these are frontier products and 
contributing to the potential confusion between 
medicines and food supplements.  
RESULTS 
• Characterization of pharmacological and natural 
therapeutic consumption for physical, intellectual 
and social performance amongst youngsters. 
AIM 
• A national survey with non-proportional quota 
sampling was used.  
• Focus groups (10 sessions; total n=57) were 
conducted previously and a questionnaire (n=1483) 
applied to university students (70%) and to workers 
with no higher studies (30%) between 18-29 y.o.   
• Statistics (IBM-SPSS-21.0) considered a 95% 
confidence interval and results are expressed as % 
of responses.  
• Ethics committee approval was obtained. 
METHODS 
• The prevalence of therapeutic consumption among 
youngsters, especially of herbal psychotropics and 
energizing drinks, was high. However, our study 
does not validate the current thought that smart 
drugs' consumption (such as metilfenidate, modafinil 
and fluoxetine) is, at least in Portugal, generalized 
amongst youngsters. 
• The study clearly demonstrates that legal 
boundaries between medicines, food supplements 
and foods are tenuous, and that natural and 
pharmacological consumption is intertwined. 
Adequate legislation is mandatory so that 
pharmacists can play a role in informed counselling 
of lifestyle drug users and in preventing health 
hazards related to their use. 
CONCLUSIONS 
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